idarubicin has been researched along with Fetal Death in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emoto, I; Kanbayashi, S; Kim, T; Maruyama, S; Moriuchi, K; Ri, Y; Sato, Y; Taga, A | 1 |
| Huerta, F; Reynoso, EE | 1 |
2 other study(ies) available for idarubicin and Fetal Death
| Article | Year |
|---|---|
Fetal death following idarubicin treatment for acute promyelocytic leukemia in pregnancy-A case report.
Topics: Adult; Antibiotics, Antineoplastic; Female; Fetal Death; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic | 2017 |
Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Death; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Remission Induction | 1994 |